
Aaron Goodman/X
Aug 15, 2024, 19:42
Aaron Goodman: Sometimes MGUS is not so benign
Aaron Goodman shared on X:
“Sometimes MGUS is not so benign!
C4
C1 inhibitor
C1q
SPEP/IFE = IgGk 0.3 g/dL
Diagnosis?
When we see this we no longer call it MGUS, we call it MGCS (monoclonal gammopathy of clinical significance).”
Read Further.
Source: Aaron Goodman/X
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego.
He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29
Feb 22, 2025, 04:19